refractory colorectal carcinoma
Showing 1 - 9 of 9
Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial in
Not yet recruiting
- Advanced Biliary Tract Carcinoma
- +32 more
- Biospecimen Collection
- +6 more
-
Chicago, IllinoisNorthwestern University
Feb 6, 2023
Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Carcinoma Trial in Houston
Active, not recruiting
- Advanced Colorectal Carcinoma
- +24 more
- Danvatirsen
- Durvalumab
-
Houston, TexasM D Anderson Cancer Center
Oct 20, 2022
Metastatic Colorectal Carcinoma, Recurrent Colon Carcinoma, Refractory Colorectal Carcinoma Trial in Livingston, New Brunswick
Recruiting
- Metastatic Colorectal Carcinoma
- +5 more
- Oxaliplatin
- Trifluridine and Tipiracil Hydrochloride
-
Elizabeth, New Jersey
- +5 more
Oct 17, 2022
Metastatic Colorectal Carcinoma, Metastatic Lung Carcinoma, Metastatic Lung Small Cell Carcinoma Trial in United States
Recruiting
- Metastatic Colorectal Carcinoma
- +29 more
- Berzosertib
- Irinotecan Hydrochloride
-
Los Angeles, California
- +22 more
Jun 28, 2022
Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma, Refractory Colorectal Carcinoma Trial in
Active, not recruiting
- Colorectal Adenocarcinoma
- +7 more
- Metformin
- Nivolumab
-
Atlanta, Georgia
- +2 more
May 6, 2022
Colon Adenocarcinoma, High-Frequency Microsatellite Instability, Metastatic Malignant Solid Tumor Trial in Houston
Active, not recruiting
- Colon Adenocarcinoma
- +10 more
- Anti-PD-L1/TGFbetaRII Fusion Protein M7824
-
Houston, TexasM D Anderson Cancer Center
Jan 12, 2022
Metastatic Colorectal Carcinoma, Recurrent Colorectal Carcinoma, Refractory Colorectal Carcinoma Trial in United States (drug,
Active, not recruiting
- Metastatic Colorectal Carcinoma
- +5 more
- Atezolizumab
- +4 more
-
Phoenix, Arizona
- +9 more
Jan 5, 2022
Refractory Colorectal Carcinoma, Stage III Colorectal Cancer AJCC v8, Stage IIIA Colorectal Cancer AJCC v8 Trial in Houston
Recruiting
- Refractory Colorectal Carcinoma
- +8 more
- Best Practice
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Sep 24, 2021
Colorectal Adenocarcinoma, CpG Island Methylator Phenotype, Metastatic Microsatellite Stable Colorectal Carcinoma Trial in Los
Withdrawn
- Colorectal Adenocarcinoma
- +7 more
- Guadecitabine
- Nivolumab
-
Los Angeles, California
- +1 more
Apr 1, 2021